General Information
Trimel Biopharma Testosterone 03
A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating The Efficacy and Safety of Intranasal Tbs-1 in The Treatment of Male Hypogonadism with Sequential Safety Extension Periods of 90 and 180 Days
| Protocol | |
|---|---|
| Identifier | TBS-1-2011-03 |
| UID | 12d8d67e-26af-4dd9-b463-9cdefd9a85bb |
| Status | PI Declined |
| Phase | 3 |
| Category | / Adult |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2011-09-13 13:14 |
| Last Updated | 2011-09-13 13:14 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Trimel Biopharma SRL |
|---|---|
| Division | Tremel Biopharma SRL |
| Team | Tremel Biopharma SRL |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gray |
| Currency | - |
